Mark T. Smith

发表

THE COMMERCIAL IMPACTS OF GREEN PRODUCT DEVELOPMENT

R. Roy, S. Potter, Mark T. Smith, 1996 .

Creating a completely “cell‐free” system for protein synthesis

Bradley C. Bundy, Mark T. Smith, A. M. Bennett, 2015, Biotechnology progress.

The emerging age of cell‐free synthetic biology

Bradley C. Bundy, Mark T. Smith, A. M. Bennett, 2014, FEBS letters.

Alternative fermentation conditions for improved Escherichia coli-based cell-free protein synthesis for proteins requiring supplemental components for proper synthesis

Anna K. Hawes, Bradley C. Bundy, Mark T. Smith, 2014 .

Eco-design Innovation in Small and Medium Sized Enterprises.

Mark T. Smith, 2001 .

Eco-innovation and market transformation

Mark T. Smith, 2001 .

Enhanced protein stability through minimally invasive, direct, covalent, and site‐specific immobilization

Bradley C. Bundy, Mark T. Smith, Jeffrey C. Wu, 2013, Biotechnology progress.

Biosensing estrogenic endocrine disruptors in human blood and urine: A RAPID cell‐free protein synthesis approach

David W. Wood, Bradley C. Bundy, D. Wood, 2018, Toxicology and applied pharmacology.

Lyophilized Escherichia coli-based cell-free systems for robust, high-density, long-term storage.

Bradley C. Bundy, Mark T. Smith, Mark Thomas Smith, 2014, BioTechniques.

Technical and economic considerations of cell culture harvest and clarification technologies

D. Britt, Mark T. Smith, W. A. Dryden, 2021 .

Developing Virus-like Particles as High-density Photoreporting Platforms using Noncanonical Amino Acids and Click Chemistry

Mark T. Smith, Bradley C. Bundty, 2013 .

Beyond heuristics: CFD‐based novel multiparameter scale‐up for geometrically disparate bioreactors demonstrated at industrial 2kL–10kL scales

Eamonn McAlea, James Scully, Laura B Considine, 2020, Biotechnology and bioengineering.

Foot-and-mouth disease: technical and political challenges to eradication.

Bradley C. Bundy, M. Grubman, Mark T. Smith, 2014, Vaccine.

Cell-Free Protein Synthesis Approach to Biosensing hTRβ-Specific Endocrine Disruptors.

David W Wood, Bradley C. Bundy, D. Wood, 2017, Analytical chemistry.

Cell‐free protein synthesis of a cytotoxic cancer therapeutic: Onconase production and a just‐add‐water cell‐free system

Bradley C. Bundy, W. Pitt, Mark T. Smith, 2016, Biotechnology journal.

Efficient tRNA degradation and quantification in Escherichia coli cell extract using RNase‐coated magnetic beads: A key step toward codon emancipation

Song-Min Schinn, Joann Diray-Arce, Bradley C. Bundy, 2017, Biotechnology progress.

The incorporation of the A2 protein to produce novel Qβ virus‐like particles using cell‐free protein synthesis

Bradley C. Bundy, Mark T. Smith, Bradley C Bundy, 2012, Biotechnology progress.

Reengineering viruses and virus-like particles through chemical functionalization strategies.

Mark Thomas Smith, Anna K Hawes, Bradley Charles Bundy, 2013, Current opinion in biotechnology.

Applied Research and Knowledge Transfer: Retaining Design Knowledge Assets in Higher Education

Bob Jerrard, Mark Thomas Smith, Isla Johnstone, 2013 .

Cell-free unnatural amino acid incorporation with alternative energy systems and linear expression templates.

Bradley Charles Bundy, Bradley C. Bundy, Mark T. Smith, 2014, New biotechnology.

An exploration of golf and voluntary environmental programmes

Mark T. Smith, D. Minoli, 2011 .

Polyvinylsulfonic acid: A Low-cost RNase inhibitor for enhanced RNA preservation and cell-free protein translation

Bradley C. Bundy, Mark T. Smith, Conner C Earl, 2017, Bioengineered.

From Concept to End Product - Computer Simulation in the Development of the EUI-200

Mark T. Smith, Celia Soteriou, Mark T. Smith, 1996 .

Cell-free unnatural amino acid incorporation with alternative energy systems and linear expression templates.

Bradley C. Bundy, Mark T. Smith, Prashanta Shrestha, 2014, New biotechnology.